AVDL

Avadel Pharmaceuticals

75 hedge funds and large institutions have $126M invested in Avadel Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

less ownership

Funds ownership:

33% less capital invested

Capital invested by funds: $189M → $126M (-$62.7M)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$678K
Puts
$594K
Net Calls
Net Calls Change

Top Buyers

1 +$1.64M
2 +$991K
3 +$833K
4
Citadel Advisors
Citadel Advisors
Florida
+$793K
5
BC
Broadfin Capital
New York
+$613K

Top Sellers

1 -$13.4M
2 -$9.45M
3 -$6.54M
4
Morgan Stanley
Morgan Stanley
New York
-$3.98M
5
GTC
Ghost Tree Capital
New York
-$2.45M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$66K
52
$66K
53
$57K
54
$34K
55
$32K
56
$30K
57
$29K
58
$28K
59
$22K
60
$21K
61
$20K
62
$7K
63
$6K
64
$3.06K
65
$3K
66
$2K
67
$2K
68
$1K
69
$1K
70
$1K
71
$1K
72
$1K
73
$2
74
75